The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis)

Journal of Bone and Joint Surgery - Series B

Volumn 94 B, Issue 7, 2012, Pages 882-888

  Van Der Heijden, L ^a   Gibbons, C L M H ^a,b   Dijkstra, P D S ^a   Kroep, J R ^a   Van Rijswijk, C S P ^a   Nout, R A ^a   Bradley, K M ^a,c   Athanasou, N A ^a,b   Hogendoorn, P C W ^a   Van De Sande, M A J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; NILOTINIB; OSTEOCLAST DIFFERENTIATION FACTOR; SUNITINIB;

ARTHROSCOPIC SURGERY; ARTHROTOMY; ARTICLE; CANCER RISK; COLLOID; EXTERNAL BEAM RADIOTHERAPY; FATIGUE; FLUID RETENTION; GIANT CELL TUMOR; HISTOPATHOLOGY; HUMAN; KNEE SURGERY; MOLECULARLY TARGETED THERAPY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PHENOTYPE; PIGMENTED VILLONODULAR SYNOVITIS; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE EFFECT; SKIN TOXICITY; SOFT TISSUE DISEASE; SYNOVECTOMY; SYNOVIUM; TENOSYNOVITIS; TUMOR GROWTH; TUMOR RECURRENCE;

ARTHROSCOPY; DIAGNOSIS, DIFFERENTIAL; GIANT CELL TUMORS; HUMANS; MAGNETIC RESONANCE IMAGING; RECURRENCE; SYNOVIAL MEMBRANE; SYNOVITIS, PIGMENTED VILLONODULAR; TENOSYNOVITIS;

EID: 84863499455     PISSN: 0301620X     EISSN: None     Source Type: Journal    
DOI: 10.1302/0301-620X.94B7.28927     Document Type: Article

References (52)

1. de St Aubain Somerhausen N, Dal Cin P. Diffuse-type giant cell tumour. In: Fletcher CD, Unni KK, Mertens F, eds. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002:112-114.
2. Jaffe HL, Lichtenstein L, Sutro CJ. Pigmented villonodular synovitis, bursitis, tenosynovitis. Arch Pathol 1941;31:731-765.
3. West RB, Rubin BP, Miller MA, et al. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci U S A 2006;103:690-695. (Pubitemid 43153087)
4. de St Aubain Somerhausen N, Dal Cin P. Giant cell tumor of tendon sheath. In: Fletcher CD, Unni KK, Mertens F, eds. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC Press, 2002;110-111.
5. Jones FE, Soule EH, Coventry MB. Fibrous xanthoma of synovium (giant-cell tumor of tendon sheath, pigmented nodular synovitis): a study of one hundred and eighteen cases. J Bone Joint Surg [Am] 1969;51-A:76-86.
6. Rao AS, Vigorita VJ. Pigmented villonodular synovitis (giant-cell tumor of the tendon sheath and synovial membrane): a review of eighty-one cases. J Bone Joint Surg [Am] 1984;66-A:76-94. (Pubitemid 14186734)
7. Giannini C, Scheithauer BW, Wenger DE, Unni KK. Pigmented villonodular synovitis of the spine: a clinical, radiological, and morphological study of 12 cases. J Neurosurg 1996;84:592-597. (Pubitemid 26104226)
8. Schwartz HS, Unni KK, Pritchard DJ. Pigmented villonodular synovitis: a retrospective review of affected large joints. Clin Orthop Relat Res 1989;247:243-255. (Pubitemid 19253014)
9. Murphey MD, Rhee JH, Lewis RB, et al. Pigmented villonodular synovitis: radiologic-pathologic correlation. Radiographics 2008;28:1493-1518.
10. Mahendra G, Kliskey K, Athanasou NA. Immunophenotypic distinction between pigmented villonodular synovitis and haemosiderotic synovitis. J Clin Pathol 2010;63:75-78.
11. Neale SD, Kristelly R, Gundle R, Quinn JM, Athanasou NA. Giant cells in pigmented villo nodular synovitis express an osteoclast phenotype. J Clin Pathol 1997;50:605-608. (Pubitemid 27359521)
12. Wood GS, Beckstead JH, Medeiros LJ, Kempson RL, Warnke RA. The cells of giant cell tumor of tendon sheath resemble osteoclasts. Am J Surg Pathol 1988;12:444-452.
13. Darling JM, Goldring SR, Harada Y, et al. Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts. Am J Pathol 1997;150:1383-1393. (Pubitemid 27152656)
14. Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010;11:275-280.
15. Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol 2005;36:945-954. (Pubitemid 41253379)
16. Taylor R, Kashima TG, Knowles H, et al. Osteoclast formation and function in pigmented villonodular synovitis. J Pathol 2011;225:151-156.
17. Cupp JS, Miller MA, Montgomery KD, et al. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol 2007;31:970-976. (Pubitemid 47165154)
18. Cassier PA, Gelderblom H, Stacchiotti S, et al. Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer 2012;118:1649-1655.
19. Bertoni F, Unni KK, Beabout JW, Sim FH. Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am J Surg Pathol 1997;21:153-163. (Pubitemid 27084054)
20. Salomao DR, Nascimento AG. Giant cell tumor of tendon sheath. In: Bulstrode C, Buckwalter J, Carr A, et al, eds. Oxford textbook of orthopaedics and trauma. Vol. 1. Oxford: Oxford University Press, 2002:211-212.
21. Moore JR, Weiland AJ, Curtis RM. Localized nodular tenosynovitis: experience with 115 cases. J Hand Surg Am 1984;9:412-417. (Pubitemid 14113302)
22. De Ponti A, Sansone V, Malchèr M. Result of arthroscopic treatment of pigmented villonodular synovitis of the knee. Arthroscopy 2003;19:602-607. (Pubitemid 36807693)
23. Ogilvie-Harris DJ, McLean J, Zarnett ME. Pigmented villonodular synovitis of the knee: the results of total arthroscopic synovectomy, partial, arthroscopic synovectomy, and arthroscopic local excision. J Bone Joint Surg [Am] 1992;74-A:119-123.
24. Zvijac JE, Lau AC, Hechtman KS, Uribe JW, Tjin-A-Tsoi EW. Arthroscopic treatment of pigmented villonodular synovitis of the knee. Arthroscopy 1999;15:613-617. (Pubitemid 29427179)
25. Sharma V, Cheng EY. Outcomes after excision of pigmented villonodular synovitis of the knee. Clin Orthop Relat Res 2009;467:2852-2858.
26. Mankin H, Trahan C, Hornicek F. Pigmented villonodular synovitis of joints. J Surg Oncol 2011;103:386-389.
27. Akinci O, Akalin Y, Incesu M, Eren A. Long-term results of surgical treatment of pigmented villonodular synovitis of the knee. Acta Orthop Traumatol Turc 2011;45:149-155.
28. Ravi V, Wang WL, Lewis VO. Treatment of tenosynovial giant cell tumor and pigmented villonodular synovitis. Curr Opin Oncol 2011;23:361-366.
29. Flandry FC, Hughston JC, Jacobson KE, et al. Surgical treatment of diffuse pigmented villonodular synovitis of the knee. Clin Orthop Relat Res 1994;300:183-192. (Pubitemid 24085495)
30. Gibbons CL, Khwaja HA, Cole AS, Cooke PH, Athanasou NA. Giant-cell tumour of the tendon sheath in the foot and ankle. J Bone Joint Surg [Br] 2002;84-B:1000-1003.
31. Labek G, Thaler M, Janda W, Agreiter M, Stöckl B. Revision rates after total joint replacement: cumulative results from worldwide joint register datasets. J Bone Joint Surg [Br] 2011;93-B:293-297.
32. Hamlin BR, Duffy GP, Trousdale RT, Morrey BF. Total knee arthroplasty in patients who have pigmented villonodular synovitis. J Bone Joint Surg [Am] 1998;80-A:76-82. (Pubitemid 28087304)
33. Vastel L, Lambert P, De Pinieux G, et al. Surgical treatment of pigmented villonodular synovitis of the hip. J Bone Joint Surg [Am] 2005;87-A:1019-1024. (Pubitemid 40617569)
34. Ozturk H, Bulut O, Oztemur Z, Bulut S. Pigmented villonodular synovitis managed by Yttrium 90 after debulking surgery. Saudi Med J 2008;29:1197-1200.
35. Shabat S, Kollender Y, Merimsky O, et al. The use of surgery and yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large joints. Rheumatology (Oxford) 2002;41:1113-1118. (Pubitemid 35203537)
36. Franssen MJ, Boerbooms AM, Karthaus RP, Buijs WC, van de Putte LB. Treatment of pigmented villonodular synovitis of the knee with yttrium-90 silicate: prospective evaluations by arthroscopy, histology, and 99mTc pertechnetate uptake measurements. Ann Rheum Dis 1989;48:1007-1013. (Pubitemid 20014804)
37. Gumpel JM, Shawe DJ. Diffuse pigmented villonodular synovitis: non-surgical management. Ann Rheum Dis 1991;50:531-533.
38. Kat S, Kutz R, Elbracht T, Weseloh G, Kuwert T. Radiosynovectomy in pigmented villonodular synovitis. Nuklearmedizin 2000;39:209-213.
39. Ottaviani S, Ayral X, Dougados M, Gossec L. Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum 2011;40:539-546.
40. Heyd R, Micke O, Berger B, et al. Radiation therapy for treatment of pigmented villonodular synovitis: results of a national patterns of care study. Int J Radiat Oncol Biol Phys 2010;78:199-204.
41. Berger B, Ganswindt U, Bamberg M, Hehr T. External beam radiotherapy as postoperative treatment of diffuse pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys 2007;67:1130-1134.
42. Horoschak M, Tran PT, Bachireddy P, et al. External beam radiation therapy enhances local control in pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys 2009;75:183-187.
43. O'Sullivan B, Cummings B, Catton C, et al. Outcome following radiation treatment for high-risk pigmented villonodular synovitis. Int J Radiat Oncol Biol Phys 1995;32:777-786.
44. Blanco CE, Leon HO, Guthrie TB. Combined partial arthroscopic synovectomy and radiation therapy for diffuse pigmented villonodular synovitis of the knee. Arthroscopy 2001;17:527-531.
45. de Visser E, Veth RP, Pruszczynski M, Wobbes T, van de Putte LB. Diffuse and localized pigmented villonodular synovitis: evaluation of treatment of 38 patients. Arch Orthop Trauma Surg 1999;119:401-404.
46. Chin KR, Barr SJ, Winalski C, Zurakowski D, Brick GW. Treatment of advanced primary and recurrent diffuse pigmented villonodular synovitis of the knee. J Bone Joint Surg [Am] 2002;84-A:2192-2202. (Pubitemid 35417699)
47. Wu CC, Pritsch T, Bickels J, Wienberg T, Malawer MM. Two incision synovectomy and radiation treatment for diffuse pigmented villonodular synovitis of the knee with extra-articular component. Knee 2007;14:99-106.
48. O'Sullivan B, Griffin A, Wunder J, et al. Sustained remission following radiation treatment for high-risk pigmented villonodular synovitis [abstract]. Int J Radiat Oncol Biol Phys 2005;63:S50.
49. Nassar WA, Bassiony AA, Elghazaly HA. Treatment of diffuse pigmented villonodular synovitis of the knee with combined surgical and radiosynovectomy. HSS J 2009;5:19-23.
50. Dewar AL, Cambareri AC, Zannettino AC, et al. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 2005;105:3127-3132.
51. Blay JY, El Sayadi H, Thiesse P, Garret J, Ray-Coquard I. Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann Oncol 2008;19:821-822. (Pubitemid 351461057)
52. Lin H, Lee E, Hestir K, et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008;320:807-811. (Pubitemid 351929632)